BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Di Costanzo A, Angelico R. Formulation Strategies for Enhancing the Bioavailability of Silymarin: The State of the Art. Molecules 2019;24:E2155. [PMID: 31181687 DOI: 10.3390/molecules24112155] [Cited by in Crossref: 61] [Cited by in F6Publishing: 66] [Article Influence: 15.3] [Reference Citation Analysis]
Number Citing Articles
1 Tedesco DEA, Guerrini A. Use of Milk Thistle in Farm and Companion Animals: A Review. Planta Med 2023. [PMID: 36302565 DOI: 10.1055/a-1969-2440] [Reference Citation Analysis]
2 Ghodousi M, Karbasforooshan H, Arabi L, Elyasi S. Silymarin as a preventive or therapeutic measure for chemotherapy and radiotherapy-induced adverse reactions: a comprehensive review of preclinical and clinical data. Eur J Clin Pharmacol 2023;79:15-38. [PMID: 36450892 DOI: 10.1007/s00228-022-03434-8] [Reference Citation Analysis]
3 Lee JA, Shin MR, Choi J, Kim M, Park HJ, Roh SS. Co-Treatments of Gardeniae Fructus and Silymarin Ameliorates Excessive Oxidative Stress-Driven Liver Fibrosis by Regulation of Hepatic Sirtuin1 Activities Using Thioacetamide-Induced Mice Model. Antioxidants (Basel) 2022;12. [PMID: 36670959 DOI: 10.3390/antiox12010097] [Reference Citation Analysis]
4 Ubaidulla U, Sinha P, Sangavi T, Rathnam G. Development of Silymarin Entrapped Chitosan Phthalate Nanoparticles for Targeting Colon Cancer. JNR 2022. [DOI: 10.18311/jnr/2022/29816] [Reference Citation Analysis]
5 Ogino M, Yamada K, Sato H, Onoue S. Enhanced nutraceutical functions of herbal oily extract employing formulation technology: The present and future. PharmaNutrition 2022;22:100318. [DOI: 10.1016/j.phanu.2022.100318] [Reference Citation Analysis]
6 Khongthaw B, Chauhan PK, Dulta K, Kumar V, Ighalo JO. A comparison of conventional and novel phytonutrient extraction techniques from various sources and their potential applications. Food Measure 2022. [DOI: 10.1007/s11694-022-01697-4] [Reference Citation Analysis]
7 Mi X, Le H, Lee S, Park H, Kim Y. Silymarin-Functionalized Selenium Nanoparticles Prevent LPS-Induced Inflammatory Response in RAW264.7 Cells through Downregulation of the PI3K/Akt/NF-κB Pathway. ACS Omega 2022. [DOI: 10.1021/acsomega.2c04140] [Reference Citation Analysis]
8 Kryl'skii ED, Sinitsyna DA, Popova TN, Shikhaliev KS, Medvedeva SM, Matasova LV, Mittova VO. The new antioxidant 1-benzoyl-6-hydroxy-2,2,4-trimethyl-1,2-dihydroquinoline has a protective effect against carbon tetrachloride-induced hepatic injury in rats. J Biomed Res 2022;36:423-34. [PMID: 36320149 DOI: 10.7555/JBR.36.20220098] [Reference Citation Analysis]
9 Karimi S, Mombeini M, Abbaspour M, Fakhredini F, Khan L. Ameliorating Effects of Silymarin-Loaded PLGA on Acetaminophen-Induced Nephrotoxicity in Mice. Jentashapir J Cell Mol Biol 2022;13. [DOI: 10.5812/jjcmb-131473] [Reference Citation Analysis]
10 Cunha C, Daniel-da-silva AL, Oliveira H. Drug Delivery Systems and Flavonoids: Current Knowledge in Melanoma Treatment and Future Perspectives. Micromachines 2022;13:1838. [DOI: 10.3390/mi13111838] [Reference Citation Analysis]
11 Mirzaei N, Jahanian Sadatmahalleh S, Rouholamin S, Nasiri M. A randomized trial assessing the efficacy of Silymarin on endometrioma-related manifestations. Sci Rep 2022;12:17549. [PMID: 36266431 DOI: 10.1038/s41598-022-22073-8] [Reference Citation Analysis]
12 Horowitz BZ. Silibinin: a toxicologist's herbal medicine? Clin Toxicol (Phila) 2022;:1-4. [PMID: 36222816 DOI: 10.1080/15563650.2022.2128815] [Reference Citation Analysis]
13 Jabeen N, Sohail M, Shah SA, Mahmood A, Khan S, Kashif MUR, Khaliq T. Silymarin nanocrystals-laden chondroitin sulphate-based thermoreversible hydrogels; A promising approach for bioavailability enhancement. Int J Biol Macromol 2022;218:456-72. [PMID: 35872320 DOI: 10.1016/j.ijbiomac.2022.07.114] [Reference Citation Analysis]
14 Aryan H, Farahani RH, Chamanara M, Elyasi S, Jaafari MR, Haddad M, Sani AT, Ardalan MA, Mosaed R. Evaluation of the efficacy of oral nano-silymarin formulation in hospitalized patients with COVID-19: A double-blind placebo-controlled clinical trial. Phytother Res 2022. [PMID: 35859298 DOI: 10.1002/ptr.7537] [Reference Citation Analysis]
15 Mohammadi M, Ariafar S, Talebi-Ghane E, Afzali S. Comparative efficacy of silibinin and nano-silibinin on lead poisoning in Male Wistar rats. Toxicology 2022;475:153242. [PMID: 35752206 DOI: 10.1016/j.tox.2022.153242] [Reference Citation Analysis]
16 Haeri V, Karimi E, Oskoueian E. Synthesized nanoliposome-encapsulated kaempferol attenuates liver health parameters and gene expression in mice challenged by cadmium-induced toxicity. Biotechnol Appl Biochem 2022. [PMID: 35696633 DOI: 10.1002/bab.2368] [Reference Citation Analysis]
17 Shete MB, Deshpande AS, Shende P. Silybin-based herbal nanocarriers: an advancement in anticancer therapy. Materials Technology. [DOI: 10.1080/10667857.2022.2081286] [Reference Citation Analysis]
18 Muthukrishnan L. Nanonutraceuticals — Challenges and Novel Nano-based Carriers for Effective Delivery and Enhanced Bioavailability. Food Bioprocess Technol. [DOI: 10.1007/s11947-022-02807-2] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
19 Xu R, Qiu S, Zhang J, Liu X, Zhang L, Xing H, You M, Wang M, Lu Y, Zhang P, Zhu J. Silibinin Schiff Base Derivatives Counteract CCl4-Induced Acute Liver Injury by Enhancing Anti-Inflammatory and Antiapoptotic Bioactivities. DDDT 2022;Volume 16:1441-1456. [DOI: 10.2147/dddt.s356847] [Reference Citation Analysis]
20 Dykman LA, Staroverov SA, Fomin AS, Gabalov KP. Obtaining antibodies to silymarin using the adjuvant properties of gold nanoparticles and their application to study the uptake of silymarin into cells. Computational Biophysics and Nanobiophotonics 2022. [DOI: 10.1117/12.2625711] [Reference Citation Analysis]
21 Alshehri FS, Kotb E, Nawaz M, Al-jameel S, Amin KA. Preparation, characterization, and antibacterial competence of silymarin and its nano-formulation. Journal of Experimental Nanoscience 2022;17:100-12. [DOI: 10.1080/17458080.2022.2041192] [Reference Citation Analysis]
22 Melim C, Magalhães M, Santos AC, Campos EJ, Cabral C. Nanoparticles as phytochemical carriers for cancer treatment: News of the last decade. Expert Opin Drug Deliv 2022. [PMID: 35166619 DOI: 10.1080/17425247.2022.2041599] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
23 Onodera R, Hayashi T, Motoyama K, Tahara K, Takeuchi H. Hydroxypropyl-β-cyclodextrin Enhances Oral Absorption of Silymarin Nanoparticles Prepared Using PureNano™ Continuous Crystallizer. Pharmaceutics 2022;14:394. [DOI: 10.3390/pharmaceutics14020394] [Reference Citation Analysis]
24 MacDonald-Ramos K, Michán L, Martínez-Ibarra A, Cerbón M. Silymarin is an ally against insulin resistance: A review. Ann Hepatol 2021;23:100255. [PMID: 32950646 DOI: 10.1016/j.aohep.2020.08.072] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 18.0] [Reference Citation Analysis]
25 Koltai T, Fliegel L. Role of Silymarin in Cancer Treatment: Facts, Hypotheses, and Questions. J Evid Based Integr Med 2022;27:2515690X211068826. [PMID: 35018864 DOI: 10.1177/2515690X211068826] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
26 Wu H, Zeng J, Wu Q, Dong J, Liang C, Wei X, Chen J, Shi S, Yang Z, Lan T. Synthesis and in vitro Anticancer Efficacy of Novel Silibinin Derivatives. HETEROCYCLES 2022;104:1111. [DOI: 10.3987/com-21-14606] [Reference Citation Analysis]
27 Li J, Gao H, Ye Z, Deng J, Ouyang D. In silico formulation prediction of drug/cyclodextrin/polymer ternary complexes by machine learning and molecular modeling techniques. Carbohydr Polym 2022;275:118712. [PMID: 34742437 DOI: 10.1016/j.carbpol.2021.118712] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
28 Paltinean G, Babes-Bolyai University, Faculty of Chemistry and Chemical Engineering, Research Centre of Physical Chemistry, Tomoaia G, Riga S, Mocanu A, Tomoaia-cotisel M, Iuliu Hatieganu University of Medicine and Pharmacy, Department of Orthopedic Surgery, Academy of Romanian Scientist, Babes-Bolyai University, Faculty of Chemistry and Chemical Engineering, Research Centre of Physical Chemistry, Academy of Romanian Scientist, Babes-Bolyai University, Faculty of Chemistry and Chemical Engineering, Research Centre of Physical Chemistry, Babes-Bolyai University, Faculty of Chemistry and Chemical Engineering, Research Centre of Physical Chemistry, Academy of Romanian Scientist. Silymarin Based Complexes – a mini review. AnnalsARSciBio 2022;11:146-166. [DOI: 10.56082/annalsarscibio.2022.1.146] [Reference Citation Analysis]
29 Schmied FP, Bernhardt A, Engel A, Klein S. A Customized Screening Tool Approach for the Development of a Self-Nanoemulsifying Drug Delivery System (SNEDDS). AAPS PharmSciTech 2021;23:39. [PMID: 34961897 DOI: 10.1208/s12249-021-02176-7] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
30 Marino M, Gardana C, Scialpi A, Giorgini G, Simonetti P, Del Bo’ C. An in vitro approach to study the absorption of a new oral formulation of berberine. PharmaNutrition 2021;18:100279. [DOI: 10.1016/j.phanu.2021.100279] [Reference Citation Analysis]
31 Budurova D, Momekova D, Momekov G, Shestakova P, Penchev H, Rangelov S. PEG-Modified tert-Octylcalix[8]arenes as Drug Delivery Nanocarriers of Silibinin. Pharmaceutics 2021;13:2025. [PMID: 34959307 DOI: 10.3390/pharmaceutics13122025] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
32 Imam SS, Alshehri S, Ghoneim MM, Zafar A, Alsaidan OA, Alruwaili NK, Gilani SJ, Rizwanullah M. Recent Advancement in Chitosan-Based Nanoparticles for Improved Oral Bioavailability and Bioactivity of Phytochemicals: Challenges and Perspectives. Polymers (Basel) 2021;13:4036. [PMID: 34833334 DOI: 10.3390/polym13224036] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
33 Gheorghita GR, Paun VI, Neagu S, Maria G, Enache M, Purcarea C, Parvulescu VI, Tudorache M. Cold-Active Lipase-Based Biocatalysts for Silymarin Valorization through Biocatalytic Acylation of Silybin. Catalysts 2021;11:1390. [DOI: 10.3390/catal11111390] [Reference Citation Analysis]
34 Moosavian SA, Sathyapalan T, Jamialahmadi T, Sahebkar A. The Emerging Role of Nanomedicine in the Management of Nonalcoholic Fatty Liver Disease: A State-of-the-Art Review. Bioinorg Chem Appl 2021;2021:4041415. [PMID: 34659388 DOI: 10.1155/2021/4041415] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
35 Sandoval-gallegos EM, Ramírez-moreno E, Vargas-mendoza N, Arias-rico J, Estrada-luna D, Cuevas-cancino JJ, Jiménez-sánchez RC, Flores-chávez OR, Baltazar-téllez RM, Morales-gonzález JA. Phytochemicals and Their Possible Mechanisms in Managing COVID-19 and Diabetes. Applied Sciences 2021;11:8163. [DOI: 10.3390/app11178163] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
36 Baral KC, Song JG, Lee SH, Bajracharya R, Sreenivasulu G, Kim M, Lee K, Han HK. Enhanced Bioavailability of AC1497, a Novel Anticancer Drug Candidate, via a Self-Nanoemulsifying Drug Delivery System. Pharmaceutics 2021;13:1142. [PMID: 34452103 DOI: 10.3390/pharmaceutics13081142] [Cited by in Crossref: 6] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
37 Poltavets YI, Kuznetsov SL, Tubasheva IA, Murav’eva AI, Gukasova NV. Nano- and Microsized Forms of Silymarin and Silybin. Nanotechnol Russia 2021;16:115-37. [DOI: 10.1134/s2635167621020105] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
38 Wang L, Yin Q, Liu C, Tang Y, Sun C, Zhuang J. Nanoformulations of Ursolic Acid: A Modern Natural Anticancer Molecule. Front Pharmacol 2021;12:706121. [PMID: 34295253 DOI: 10.3389/fphar.2021.706121] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
39 Zare M, Sarkati MN. Chitosan‐functionalized Fe 3 O 4 nanoparticles as an excellent biocompatible nanocarrier for silymarin delivery. Polymers for Advanced Techs 2021;32:4094-100. [DOI: 10.1002/pat.5416] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
40 Mohylyuk V, Pauly T, Dobrovolnyi O, Scott N, Jones DS, Andrews GP. Effect of carrier type and Tween® 80 concentration on the release of silymarin from amorphous solid dispersions. Journal of Drug Delivery Science and Technology 2021;63:102416. [DOI: 10.1016/j.jddst.2021.102416] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
41 Song IS, Nam SJ, Jeon JH, Park SJ, Choi MK. Enhanced Bioavailability and Efficacy of Silymarin Solid Dispersion in Rats with Acetaminophen-Induced Hepatotoxicity. Pharmaceutics 2021;13:628. [PMID: 33925040 DOI: 10.3390/pharmaceutics13050628] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
42 Chrubasik-hausmann S. Mariendistel – Arzneipflanze des Jahres 2021 in Österreich. Zeitschrift für Komplementärmedizin 2021;13:50-53. [DOI: 10.1055/a-1410-1576] [Reference Citation Analysis]
43 Takke A, Shende P. Magnetic-core-based silibinin nanopolymeric carriers for the treatment of renal cell cancer. Life Sci 2021;275:119377. [PMID: 33757771 DOI: 10.1016/j.lfs.2021.119377] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
44 Bahman MR, Feldman NB, Orekhov SN, Sedyakina NE, Gromovykh TI, Lutsenko SV. Saturation of Bacterial Cellulose with Silymarin Flavolignans in the Composition of Lipid Nanoparticles. Nanotechnol Russia 2021;16:239-245. [DOI: 10.1134/s2635167621020038] [Reference Citation Analysis]
45 Tvrdý V, Pourová J, Jirkovský E, Křen V, Valentová K, Mladěnka P. Systematic review of pharmacokinetics and potential pharmacokinetic interactions of flavonolignans from silymarin. Med Res Rev 2021;41:2195-246. [PMID: 33587317 DOI: 10.1002/med.21791] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
46 Golestaneh E, Aslani A, Aghaei M, Hashemnia M, Aarabi MH. Preparation and characterisation of a new form of silymarin as a potential antidiabetic agent in the adult male rat. Arch Physiol Biochem 2021;:1-11. [PMID: 33529090 DOI: 10.1080/13813455.2021.1874018] [Reference Citation Analysis]
47 Marková I, Malínská H, Hüttl M, Miklánková D, Oliyarnyk O, Poruba M, Rácová Z, Kazdová L, Večeřa R. The combination of atorvastatin with silymarin enhances hypolipidemic, antioxidant and anti-inflammatory effects in a rat model of metabolic syndrome. Physiol Res 2021;70:33-43. [PMID: 33453720 DOI: 10.33549/physiolres.934587] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
48 Ezhilarasan D. Advantages and challenges in nanomedicines for chronic liver diseases: A hepatologist's perspectives. Eur J Pharmacol 2021;893:173832. [PMID: 33359144 DOI: 10.1016/j.ejphar.2020.173832] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
49 Faryadi S, Sheikhahmadi A, Farhadi A, Nourbakhsh H. Effects of silymarin and nano-silymarin on performance, egg quality, nutrient digestibility, and intestinal morphology of laying hens during storage. Italian Journal of Animal Science 2021;20:1633-1644. [DOI: 10.1080/1828051x.2021.1975503] [Reference Citation Analysis]
50 Bahrami M, Mosayebi G, Ghazavi A, Ganji A. Immunomodulation in Multiple Sclerosis by Phytotherapy. CIR 2020;16:28-36. [DOI: 10.2174/1573395516999200930122850] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
51 Sola-Barrado B, M Leite D, Scarpa E, Duro-Castano A, Battaglia G. Combinatorial Intracellular Delivery Screening of Anticancer Drugs. Mol Pharm 2020;17:4709-14. [PMID: 33175550 DOI: 10.1021/acs.molpharmaceut.0c00791] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
52 Kesharwani SS, Jain V, Dey S, Sharma S, Mallya P, Kumar VA. An overview of advanced formulation and nanotechnology-based approaches for solubility and bioavailability enhancement of silymarin. Journal of Drug Delivery Science and Technology 2020;60:102021. [DOI: 10.1016/j.jddst.2020.102021] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
53 Meresman GF, Götte M, Laschke MW. Plants as source of new therapies for endometriosis: a review of preclinical and clinical studies. Hum Reprod Update 2021;27:367-92. [PMID: 33124671 DOI: 10.1093/humupd/dmaa039] [Cited by in Crossref: 29] [Cited by in F6Publishing: 35] [Article Influence: 9.7] [Reference Citation Analysis]
54 Sola-barrado B, Leite DM, Scarpa E, Duro-castano A, Battaglia G. Combinatorial Intracellular Delivery Screening (CIDS) of Anticancer Drugs.. [DOI: 10.1101/2020.08.28.271429] [Reference Citation Analysis]
55 Jiang Y, Song H, Jiang L, Qiao Y, Yang D, Wang D, Li J. Silybin Prevents Prostate Cancer by Inhibited the ALDH1A1 Expression in the Retinol Metabolism Pathway. Front Cell Dev Biol 2020;8:574394. [PMID: 32984354 DOI: 10.3389/fcell.2020.574394] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 3.3] [Reference Citation Analysis]
56 Kesharwani SS, Mallya P, Kumar VA, Jain V, Sharma S, Dey S. Nobiletin as a Molecule for Formulation Development: An Overview of Advanced Formulation and Nanotechnology-Based Strategies of Nobiletin. AAPS PharmSciTech 2020;21:226. [PMID: 32761293 DOI: 10.1208/s12249-020-01767-0] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.7] [Reference Citation Analysis]
57 Aktaş İ, Sevimli M. The Treatment Effect of Silymarin on Brain Damage in Rats. Van Veterinary Journal 2020. [DOI: 10.36483/vanvetj.658220] [Reference Citation Analysis]
58 Zayed A, Serag A, Farag MA. Cynara cardunculus L.: Outgoing and potential trends of phytochemical, industrial, nutritive and medicinal merits. Journal of Functional Foods 2020;69:103937. [DOI: 10.1016/j.jff.2020.103937] [Cited by in Crossref: 30] [Cited by in F6Publishing: 32] [Article Influence: 10.0] [Reference Citation Analysis]
59 Tseng YY, Yang TC, Chen SM, Yang ST, Tang YL, Liu SJ. Injectable SN-38-embedded Polymeric Microparticles Promote Antitumor Efficacy against Malignant Glioma in an Animal Model. Pharmaceutics 2020;12:E479. [PMID: 32456305 DOI: 10.3390/pharmaceutics12050479] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
60 Delmas D. Silymarin and Derivatives: From Biosynthesis to Health Benefits. Molecules 2020;25:E2415. [PMID: 32455869 DOI: 10.3390/molecules25102415] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
61 Dewanjee S, Chakraborty P, Mukherjee B, De Feo V. Plant-Based Antidiabetic Nanoformulations: The Emerging Paradigm for Effective Therapy. Int J Mol Sci 2020;21:E2217. [PMID: 32210082 DOI: 10.3390/ijms21062217] [Cited by in Crossref: 38] [Cited by in F6Publishing: 44] [Article Influence: 12.7] [Reference Citation Analysis]
62 Lee MK. Liposomes for Enhanced Bioavailability of Water-Insoluble Drugs: In Vivo Evidence and Recent Approaches. Pharmaceutics 2020;12:E264. [PMID: 32183185 DOI: 10.3390/pharmaceutics12030264] [Cited by in Crossref: 69] [Cited by in F6Publishing: 72] [Article Influence: 23.0] [Reference Citation Analysis]
63 Sheta NM, Elfeky YA, Boshra SA. Cardioprotective Efficacy of Silymarin Liquisolid in Isoproterenol Prompted Myocardial Infarction in Rats. AAPS PharmSciTech 2020;21:81. [PMID: 31974855 DOI: 10.1208/s12249-019-1609-3] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
64 Staroń A, Długosz O, Pulit-Prociak J, Banach M. Analysis of the Exposure of Organisms to the Action of Nanomaterials. Materials (Basel) 2020;13:E349. [PMID: 31940903 DOI: 10.3390/ma13020349] [Cited by in Crossref: 21] [Cited by in F6Publishing: 24] [Article Influence: 7.0] [Reference Citation Analysis]
65 Chi C, Zhang C, Liu Y, Nie H, Zhou J, Ding Y. Phytosome-nanosuspensions for silybin-phospholipid complex with increased bioavailability and hepatoprotection efficacy. Eur J Pharm Sci 2020;144:105212. [PMID: 31923602 DOI: 10.1016/j.ejps.2020.105212] [Cited by in Crossref: 28] [Cited by in F6Publishing: 32] [Article Influence: 9.3] [Reference Citation Analysis]
66 Rai VK, Gupta GD, Pottoo FH, Barkat MA. Potential of Nano-Structured Drug Delivery System for Phytomedicine Delivery. Nanophytomedicine 2020. [DOI: 10.1007/978-981-15-4909-0_6] [Reference Citation Analysis]
67 Milinčić DD, Popović DA, Lević SM, Kostić AŽ, Tešić ŽL, Nedović VA, Pešić MB. Application of Polyphenol-Loaded Nanoparticles in Food Industry. Nanomaterials (Basel) 2019;9:E1629. [PMID: 31744091 DOI: 10.3390/nano9111629] [Cited by in Crossref: 58] [Cited by in F6Publishing: 59] [Article Influence: 14.5] [Reference Citation Analysis]